You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian sarcoma

Showing 1 - 25 of 5,326
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

Available
  • Glioblastoma
  • +13 more
  • (no location specified)
Jul 26, 2023

Ovarian Cancer, AIDS-related Kaposi Sarcoma, Multiple Myeloma Trial (DOXIL/CAELYX)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Jan 3, 2023

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Santa Monica, California
  • +4 more
Jul 26, 2022

Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

Recruiting
  • Genetic Testing
  • +8 more
  • Video Education
  • Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 31, 2022

Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • (no location specified)
Jul 12, 2023

International PPB/DICER1 Registry

Recruiting
  • Pleuropulmonary Blastoma
  • +14 more
    • Minneapolis, Minnesota
      Children's Minnesota
    Aug 16, 2022

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +8 more
    • Springdale, Arkansas
      Highlands Oncology
    Nov 11, 2022

    Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

    Not yet recruiting
    • Cervical Cancer
    • +13 more
    • (no location specified)
    Sep 28, 2022

    Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

    Recruiting
    • Malignant Abdominal Neoplasm
    • +26 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

    Recruiting
    • Advanced Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +4 more
    Dec 12, 2022

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

    Completed
    • Pancreas Cancer
    • +6 more
    • Rozzano, Milan, Italy
      Istituto Clinico Humanitas
    Sep 9, 2022

    Ovarian Carcinoma, Soft Tissue Sarcoma Trial in Bordeaux, Lyon (Combination of trabectedin with durvalumab)

    Active, not recruiting
    • Ovarian Carcinoma
    • Soft Tissue Sarcoma
    • Combination of trabectedin with durvalumab
    • Bordeaux, France
    • +1 more
    May 4, 2021

    Solid Tumor, Ewing Sarcoma, Ewing's Tumor Metastatic Trial in Dallas (Vigil)

    Temporarily not available
    • Solid Tumor
    • +7 more
    • Vigil
    • Dallas, Texas
      Texas Oncology - Pediatrics
    Feb 9, 2022

    Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

    Recruiting
    • Pelvic Cancer
    • +8 more
    • Ultrasound guided tru-cut biopsy
    • Leuven, Belgium
    • +3 more
    Nov 3, 2022

    Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

    Recruiting
    • Solid Tumor, Adult
    • +11 more
    • New Haven, Connecticut
    • +3 more
    May 9, 2022

    Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

    Active, not recruiting
    • Urinary Bladder Cancer
    • +9 more
    • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
    • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
    • Miami, Florida
    • +10 more
    Aug 9, 2022

    Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

    Recruiting
    • Sarcoma, Synovial
    • +8 more
    • CYCLOPHOSPHAMIDE and FLUDARABIN
    • +3 more
    • Jerusalem, Israel
      Hadassah Medical Organization
    Mar 15, 2022

    Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +66 more
    • Best Practice
    • +3 more
    • Fullerton, California
      Virginia K Crosson Cancer Center
    Jan 31, 2022

    Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

    Recruiting
    • Lung Cancer
    • +11 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Anqing, Anhui, China
      The PLA Navy Anqing Hospital
    May 23, 2023

    Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

    Recruiting
    • Metastatic Esophageal
    • +7 more
    • LVGN3616 + LVGN6051 + Nab-Paclitaxel
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Validation for Early Cancer Detection and Minimal Residual

    Recruiting
    • Brain Cancer
    • +19 more
      • Duarte, California
      • +6 more
      Nov 10, 2022

      Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

      Not yet recruiting
      • Cancer
      • +16 more
      • KVA12123 - Dose Escalation
      • +3 more
      • (no location specified)
      Feb 2, 2023

      Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

      Active, not recruiting
      • Clinical Stage IV Cutaneous Melanoma AJCC v8
      • +20 more
      • Pembrolizumab
      • Ziv-Aflibercept
      • Tampa, Florida
      • +8 more
      Jan 3, 2023